Skip to main content
NIH funding notice PAS-19-393

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed)

Closed on March 16, 2023.

Posted
October 7, 2019
Close date
March 16, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,844,558 in first-year total cost, median $165,383.

Most frequent study sections

  1. Molecular Neurogenetics Study Section[MNG]3
  2. Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]1
  3. Clinical Neuroimmunology and Brain Tumors Study Section[CNBT]1
  4. Clinical Neuroscience and Neurodegeneration Study Section[CNN]1
  5. Emerging Imaging Technologies in Neuroscience Study Section[EITN]1

Most frequent institutions

  1. BROWN UNIVERSITY1
  2. CLEVELAND CLINIC LERNER COM-CWRU1
  3. HEBREW REHABILITATION CENTER FOR AGED1
  4. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  5. UNIV OF NORTH CAROLINA CHAPEL HILL1
Competing awards under PAS-19-393 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Early Alzheimers Forecasting from Multimodal Data via Deep Transfer Learning, Evaluated on a Large-Scale Prospective Cohort Study1R03AG083708-01DUTTA, JOYITAFITERAU BROSTEAN, MADALINAUNIVERSITY OF MASSACHUSETTS AMHERST, MA$287,118EITN
2022Statistical methods for studying cell-cell interactions using spatial transcriptomics for Alzheimer's disease1R03AG075567-01SONG, XIAOYUICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$169,000MNG
2022System biology approach to decode molecular mechanism of glucose metabolism in AD and dementia1R03AG072233-01A1JEONG, SOHYUNHEBREW REHABILITATION CENTER FOR AGED, MA$160,000MNG
2021Lipopolysaccharide Binding Protein and Lipopolysaccharide and Inflammation in Alzheimer's Disease1R03AG069815-01SHARP, FRANK RZHAN, XINHUAUNIVERSITY OF CALIFORNIA AT DAVIS, CA$314,000CNN
2021Steroid signaling in the choroid plexus of the aging brain1R03AG070755-01GARRISON, JENNIFER LLISHKO, POLINA VUNIVERSITY OF CALIFORNIA BERKELEY, CA$273,807CDIN
2021Uncovering the Heterogeneity of Neurodegeneration Trajectories in Alzheimer's Disease Using a Network Guided Reaction-Diffusion Model1R03AG073927-01WU, GUORONGUNIV OF NORTH CAROLINA CHAPEL HILL, NC$165,383ZRG1
2021Integrative analysis of multi-omics data to delineate CCL2 associated inflammatory pathways in Alzheimers Disease1R03AG070477-01BEBEK, GURKANPILLAI, JAGAN AYYAPPANCLEVELAND CLINIC LERNER COM-CWRU, OH$161,000CNBT
2021Transcriptomic and epigenomic landscape of neurodegenerative disease models1R03AG070529-01WOOD, JASON GLENBROWN UNIVERSITY, RI$158,750MNG
2021Molecular consequences of protein regulation on amyloid plaque burden1R03AG070686-01A1RHOADS, TIMOTHY W.UNIVERSITY OF WISCONSIN-MADISON, WI$155,500ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAS-19-393: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) | ScienceDex | ConductScience